← All insiders

APGE

Apogee Therapeutics, Inc.

43 transactions on file, per SEC Form 4 filings.

Fairmount Funds Management LLC

director · 2026-09-03

D-Return

$6.9M

Fairmount Funds Management LLC

director · 2026-09-03

D-Return

6,743,321 sh

Fairmount Funds Management LLC

director · 2026-09-03

D-Return

$812K

Fairmount Funds Management LLC

director · 2026-09-03

D-Return

$455K

Fairmount Funds Management LLC

director · 2026-09-03

D-Return

$602K

Fairmount Funds Management LLC

director · 2026-09-03

D-Return

$651K

McKenna Mark C.

director · 2026-09-03

D-Return

20,000 sh

McKenna Mark C.

director · 2026-09-03

D-Return

$3.5M

McKenna Mark C.

director · 2026-09-03

D-Return

$455K

McKenna Mark C.

director · 2026-09-03

D-Return

$602K

McKenna Mark C.

director · 2026-09-03

D-Return

$651K

JONES WILLIAM A JR

director · 2026-09-03

D-Return

34,824 sh

JONES WILLIAM A JR

director · 2026-09-03

D-Return

$455K

JONES WILLIAM A JR

director · 2026-09-03

D-Return

$602K

JONES WILLIAM A JR

director · 2026-09-03

D-Return

$651K

Dambkowski Carl

Chief Medical Officer · 2026-09-03

D-Return

167,123 sh

Dambkowski Carl

Chief Medical Officer · 2026-09-03

D-Return

$2.5M

Dambkowski Carl

Chief Medical Officer · 2026-09-03

D-Return

$6.1M

Dambkowski Carl

Chief Medical Officer · 2026-09-03

D-Return

$6.3M

Fox Jennifer A.

director · 2026-09-03

D-Return

34,824 sh

Fox Jennifer A.

director · 2026-09-03

D-Return

$455K

Fox Jennifer A.

director · 2026-09-03

D-Return

$602K

Fox Jennifer A.

director · 2026-09-03

D-Return

$651K

Henderson Jane

Chief Financial Officer · 2026-09-03

D-Return

158,371 sh

Henderson Jane

Chief Financial Officer · 2026-09-03

D-Return

$4.0M

Henderson Jane

Chief Financial Officer · 2026-09-03

D-Return

$6.1M

Henderson Jane

Chief Financial Officer · 2026-09-03

D-Return

$6.3M

Bollinger Lisa

director · 2026-09-03

D-Return

$888K

Bollinger Lisa

director · 2026-09-03

D-Return

$356K

Bollinger Lisa

director · 2026-09-03

D-Return

$602K

Bollinger Lisa

director · 2026-09-03

D-Return

$651K

HENDERSON MICHAEL THOMAS

Chief Executive Officer · 2026-09-03

D-Return

920,941 sh

HENDERSON MICHAEL THOMAS

Chief Executive Officer · 2026-09-03

D-Return

$8.8M

HENDERSON MICHAEL THOMAS

Chief Executive Officer · 2026-09-03

D-Return

$17.5M

HENDERSON MICHAEL THOMAS

Chief Executive Officer · 2026-09-03

D-Return

$19.2M

Shah Nimish P

director · 2026-09-03

D-Return

$236.4M

Shah Nimish P

director · 2026-09-03

D-Return

6,743,321 sh

Shah Nimish P

director · 2026-09-03

D-Return

$812K

Shah Nimish P

director · 2026-09-03

D-Return

$455K

Shah Nimish P

director · 2026-09-03

D-Return

$602K

Shah Nimish P

director · 2026-09-03

D-Return

$651K

Shah Nimish P

director · 2026-09-03

D-Return

365,853 sh

Dambkowski Carl

Chief Medical Officer · 2026-09-02

D-Return

$186K

Each row links to the underlying SEC filing. Sells are shown for transparency, not as a signal — see the insider trading article for why.

Is APGE actually a buy?

Following an insider into a stock isn't a strategy on its own. Run your own margin-of-safety analysis, free.

Analyze APGE